NCT02885974View on ClinicalTrials.gov

Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2025

Conditions
Bladder Cancer
Interventions
DRUG

Celecoxib

Celecoxib (100 mg daily)

DRUG

Gemcitabine

1,000 mg/m2 (IV), on Days 1 and 8 of each 21-day cycle. Up to 4 cycles.

DRUG

Cisplatin

70 mg/m2 (IV), on Day 1 of each 21-day cycle. Up to 4 cycles.

Trial Locations (2)

77030

Baylor Clinic, Houston

77054

Harris Health System - Smith Clinic, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT02885974 - Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter